Factor XI Inhibitor Abelacimab Cuts Bleeding Risk Across Age Groups in Atrial FibrillationAmong adults with atrial fibrillation (AF), those who received the factor XI inhibitor abelacimab had a lower risk for major or clinically relevant nonmajor bleeding than those who received the oral anticoagulant rivaroxaban across age groups, with greater absolute risk reductions in older adults.
High Salivary Aldosterone Can Signal Future Heart DiseaseResearchers cross-sectionally compared the salivary free AldAR among men with coronary heart disease, essential hypertension, and normotension and prospectively evaluated whether the AldAR could predict the risk for coronary heart disease.
Weight Gain Risks: The Ultraprocessed Food ConnectionResearchers analyzed data from 24,453 Brazilian adults (79.7% women) in the NutriNet Brasil cohort study, who were followed up for a median of 43.6 months, to assess the association between consumption of ultraprocessed foods and weight gain.
Low Vitamin D Levels Signal Increased Heart Risk in SeniorsIn older adults, lower levels of vitamin D metabolites and periostin, a protein involved in remodelling and repairing tissues, were linked to an increased cardiovascular (CV) risk. Low periostin levels were correlated with low vitamin D levels, and when all three markers were considered together, only the active form of vitamin D independently predicted the CV risk.
Mapping the evidence on mHealth interventions for cardiovascular event care in Africa: a scoping reviewThe burden of cardiovascular disease in Africa is projected to increase significantly over the next decade, placing additional strain on already overburdened healthcare systems. Mobile health (mHealth) technologies represent a promising approach to addressing these challenges. This review analyzes the use of mHealth solutions in cardiovascular care in Africa.
RU
EN